OUR AREAS OF INTEREST


Biologics

Areas of Interest:

  • Biosimilars
  • Novel biologics and biobetters that fit franchise strategies
  • Novel devices for SQ and IV delivery

Technologies of Interest:

  • Fc engineering to enhance / improve effector functions, half-life
  • Targeted delivery technologies that:
    • Address / overcome the blood brain barrier
    • Glycan mediated targeting
  • Technologies that enhance expression, production, formulation, stability, and bioavailability (via SQ admin) of proteins
  • Platforms for the identification, generation, and modification of monoclonal antibodies (mAbs, Fabs, scFvs) to ion channels
  • Platforms for the generation and modification of engineered proteins displaying pharmaceutical properties
  • High throughput antibody screening
    • especially functional screens

Not Interested in:

  • Transgenic animal-based or plant-based production systems for therapeutics

Areas of Interest

Click on the icons below for more information about your areas of interest.

Research & Enabling Technologies Atherosclerosis and Cardiovascular Diseases Biologics Respiratory and Immunology Diabetes and Endocrinology Infectious Diseases Neurosciences and Ophthalmology Oncology Therapeutics Vaccines

Have a Discovery?

If you think something you discovered might be of interest to Merck, contact one of our scientific scouts.

Learn more about us

TRUSTe - Click to Verify   This Web This Web Accessibility icon serves as a link to download eSSENTIAL Accessibility assistive technology software for individuals with physical disabilities. It is being featured as part of a Disability Community Involvement initiative that reflects our commitment to Diversity, Inclusion,Corporate Citizenship and Social Responsibility.